This is due to its high tumor heterogeneity, rapid proliferation and early metastasis.1,2 TNBC lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2),3,4 which eliminates the possibility of using targeted therapies. Here, PGR is linked to neoplasm.